Your Article Summary
Aspects relevant for functioning in patients with ankylosing spondylitis according to the health professionals: A Delphi study with the ICF as reference
Rheumatology, 06/24/09
Boonen A et al. – Study reports that 141 International Classification of Functioning, Disability and Health (ICF) categories and 2 personal factors represent the reference of functioning in AS from the perspective of health professional. The impact of AS on participation in life situations and the role of environmental factors were underscored.
Methods- Aim was to achieve consensus on which aspects of functioning are typical and relevant for AS pts using ICF as reference
- An international Delphi study through e-mail was performed among different health professions
- Of the 267 experts invited, 126 agreed to participate and 74 participated in all rounds
- 28 were rheumatologists, 6 rheumatology nurses, 24 physiotherapists, 2 occupational therapists, 4 psychologists, 8 rehabilitation physicians and 2 social workers
- More than 80% agreement was reached on 141 ICF categories:
- 30 (21%) were part of Body functions
- 27 (19%) of body structures
- 56 (40%) of activities and participation; and
- 28 (20%) of environmental factors
- In addition, 2 personal factors: illness knowledge and coping were agreed upon
Related Articles
Evaluation of inflammation and oxidative stress in ankylosing spondylitis: a role for macrophage migration inhibitory factor
Modern Rheumatology, 10/05/09
Relevance Score: 69%
Erythrocyte sedimentation rate, CRP level, and serum amyloid a protein for patient selection and monitoring of anti-tumor necrosis factor treatment in ankylosing spondylitis
Arthritis Care and Research, 11/02/09
Relevance Score: 68%
Uncommon case of ankylosing spondylitis associated with spontaneous occurring hypoparathyroidism
Rheumatology International, 11/11/09
Relevance Score: 67%
Concomitant cervical and thoracic spinal fractures in ankylosing spondylitis: A case report and review of literature
Injury Extra, 11/05/09
Relevance Score: 67%
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis
Rheumatology International, 10/27/09
Relevance Score: 67%
Today in Spondylarthropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Programmed cell death 1 gene polymorphisms is associated with ankylosing spondylitis in Chinese Han population
Rheumatology International, 12/16/09
Human leukocyte antigen-G in ankylosing spondylitis and the response after tumour necrosis factor-&alpha blocker therapy
Rheumatology, 12/15/09
Fetuin-A and interleukin-18 levels in ankylosing spondylitis
International Journal of Rheumatic Diseases, 12/15/09

See Latest Articles